8VC — 2018 Investments
3 investments dated 2018 · listed companies and verified rows first · show all
Senti Bio develops cell and gene therapies for cancer and difficult-to-treat diseases using synthetic biology and engineered Gene Circuits to enhance precision, control, and selectivity in targeting tumor cells.
BiotechDeep TechMedical DevicesSouth San Francisco, US
Tim Lu(Co-Founder and Chief Executive Officer)inPhilip Lee(Executive Officer)Kanya Rajangam(President, Head of Research & Development and Chief Medical Officer)Yvonne Li(Executive Officer)James Collins(Director)
BoardDonald Tang(Director)
Board seatAlex Kolicich· per SEC Form D
Co-investorsEvolution VC PartnersFlucas VenturesLifeforce CapitalLux CapitalMenlo VenturesNew Enterprise Associates (NEA)+2 more
Trackonomy develops an operating system and software platform to add connectivity and AI-driven intelligence across supply chain endpoints.
AI & Machine LearningEnterprise SoftwareIoTLogistics & Supply ChainSanta Clara, US
Ajay Khoche(Executive Officer, Director)inErik Volkerink(Executive Officer, Director)in
Board seatJake Medwell· per SEC Form D
Co-investorsHuman CapitalKoch Disruptive TechnologiesKleiner Perkins
Forethought builds self-improving AI agents for customer service, now integrated into Zendesk's platform.
AI & Machine LearningEnterprise SoftwareSaaSSan Mateo, US
Deon Chris Nicholas(Founder)Deon Nicholas(Founder)inSami Ghoche(Founder)in
Co-investorsFrontline VenturesGeodesic CapitalInspired CapitalK9 VenturesNew Enterprise Associates (NEA)Village Global+4 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.